arrow
M

Marta Sbaraglia

department of medicine, university of padua, padua, italy
H指数:34
被引数:6,691

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase 2 study from the Italian Sarcoma Group

Trabectedin-olaparib联合治疗或trabectedin单药治疗在经蒽环类为基础治疗失败的晚期软组织肉瘤中的应用(TOMAS2):一项来自意大利肉瘤组的随机Ⅱ期研究

2025-12-050
PRE
Solitary fibrous tumour: histological discoveries, behavioural aspects, risk assessment and therapeutical approaches

孤立性纤维瘤:组织学发现、行为特征、风险评估和治疗方法

2025-10-220
OA
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group

间质肿瘤的扩展分子分析:意大利肉瘤组共识论文

2025-09-230
PREAI
Reactive Bcl2-positive germinal centres in paediatric tonsils: expanding the spectrum of lymphoma mimickers in children and adolescents

儿童扁桃体中反应性Bcl2阳性的生发中心:扩展儿童和青少年淋巴瘤模拟物的谱系

2025-04-270
PRE
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively
2025-01-010
OAAI
Low-grade fi bromyxoid sarcoma and sclerosing epithelioid fi brosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
2024-09-010
OAAI
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models
2024-08-280
OAAI
Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
2024-08-011
OAAI
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)

接受免疫治疗的晚期肾细胞癌患者的肿瘤微环境分析 (Meet-URO 18研究)

2024-06-120
PRE
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
2024-05-012
OAAI
Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment
2024-03-012
OAAI